Why Ozempic keeps wowing the world
· 14 min
Episode Why Ozempic keeps wowing the world
GLP-1 drugs were first approved to treat diabetes and then caused a frenzy when it was discovered they were great for weight loss.
But now scientists are discovering the drugs that have brand names including Ozempic and Mounjaro might offer so much more, from reducing the risk of heart attack to treating kidney disease.
Today, Doctor Paul Joyce, a pharmaceutical scientist at Adelaide University on how Ozempic is shaking things up, again.
Featured:
Doctor Paul Joyce, a pharmaceutical scientist at Adelaide University
Shows are listed from Apple Podcasts' charts and directory, and Podcast Index where it is used. Every show and episode belongs to its publisher and plays from the publisher's own feed; this site hosts none of them. Explicit shows are for adult profiles only, and children’s profiles hear only children’s shows. More about this list.